- Home
- LNG vs KVUE Comparison
LNG vs KVUE Comparison
Compare LNG & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNG
- KVUE
- Stock Information
- Founded
- LNG 1983
- KVUE 2022
- Country
- LNG United States
- KVUE United States
- Employees
- LNG 1714
- KVUE N/A
- Industry
- LNG Oil/Gas Transmission
- KVUE Specialty Chemicals
- Sector
- LNG Utilities
- KVUE Consumer Discretionary
- Exchange
- LNG Nasdaq
- KVUE Nasdaq
- Market Cap
- LNG 49.1B
- KVUE 43.6B
- IPO Year
- LNG 1997
- KVUE 2023
- Fundamental
- Price
- LNG $231.45
- KVUE $23.39
- Analyst Decision
- LNG Strong Buy
- KVUE Buy
- Analyst Count
- LNG 14
- KVUE 13
- Target Price
- LNG $236.14
- KVUE $24.42
- AVG Volume (30 Days)
- LNG 2.5M
- KVUE 18.2M
- Earning Date
- LNG 05-08-2025
- KVUE 05-06-2025
- Dividend Yield
- LNG 0.86%
- KVUE 3.51%
- EPS Growth
- LNG N/A
- KVUE N/A
- EPS
- LNG 14.20
- KVUE 0.54
- Revenue
- LNG $15,454,000,000.00
- KVUE $15,455,000,000.00
- Revenue This Year
- LNG $31.46
- KVUE $1.84
- Revenue Next Year
- LNG $13.54
- KVUE $3.98
- P/E Ratio
- LNG $16.30
- KVUE $43.49
- Revenue Growth
- LNG N/A
- KVUE 0.07
- 52 Week Low
- LNG $153.03
- KVUE $17.67
- 52 Week High
- LNG $257.65
- KVUE $24.46
- Technical
- Relative Strength Index (RSI)
- LNG 57.32
- KVUE 56.80
- Support Level
- LNG $199.11
- KVUE $20.96
- Resistance Level
- LNG $221.70
- KVUE $24.23
- Average True Range (ATR)
- LNG 11.19
- KVUE 0.77
- MACD
- LNG 1.34
- KVUE 0.02
- Stochastic Oscillator
- LNG 91.11
- KVUE 74.31
About LNG Cheniere Energy Inc.
Cheniere Energy is a liquified natural gas, or LNG, producer with two facilities in Corpus Christi, Texas and Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed and variable fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. A subsidiary, Cheniere Energy Partners, owns the Sabine Pass facility and trades as a master limited partnership.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.